LG Chem Ltd. became the world's largest supplier of electric vehicle (EV) batteries in the first half by taking a 24.6 percent market share, up from last year's 10.4 percent.
Date by SNE Research also revealed that 10.5 gigawatt-hours (GWh) of LG Chem's EV batteries were used in the first half, almost doubling the 5.7 GWh from a year earlier.
The hike was attributed to robust sales of the Tesla Model 3, Audi e-Tron EV, and Renault Zoe EV, which are all powered by LG Chem's EV batteries.
China's CATL came in with a 23.5 percent market share, down from 25.1 percent last year.
Other South Korean EV battery makers, Samsung SDI Co., and SK Innovation Co. came in at fourth and sixth places with 6 percent and 3.9 percent market shares.
The strong performance of Korean EV battery makers came as the combined global usage of EV batteries went down to 42.6 GWh in the second quarter, 23 percent less from the 55.3 GWh used in the same period last year.


Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
Berkshire Hathaway Q1 Earnings Jump 18% as Greg Abel Signals Disciplined Growth Strategy
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth
Google Secures Pentagon AI Deal for Classified Projects
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth 



